Joshua S. Prince's Insider Trades & SAST Disclosures

Joshua S. Prince's most recent trade in VistaGen Therapeutics Inc was a trade of 56,248 Non-Qualified Stock Option (right to buy) done . Disclosure was reported to the exchange on April 7, 2026.

Share

Note

This is a custom search result for pattern Joshua S. Prince.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
VistaGen Therapeutics Inc	Joshua S. Prince	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Apr 2026	56,248	56,248	-		-	Non-Qualified Stock Option (right to buy)
VistaGen Therapeutics Inc	Joshua S. Prince	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Apr 2026	18,752	18,752	-		-	Incentive Stock Option (right to buy)
VistaGen Therapeutics Inc	Joshua S. Prince	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.56 per share.	31 Dec 2025	4,386	15,249 (0%)	0%	0.6	2,468	Common Stock
VistaGen Therapeutics Inc	Joshua S. Prince	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 1.70 per share.	30 Jun 2025	4,882	10,863 (0%)	0%	1.7	8,299	Common Stock
VistaGen Therapeutics Inc	Joshua S. Prince	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2025	100,000	100,000	-		-	Stock Option (Right to Buy)
VistaGen Therapeutics Inc	Joshua S. Prince	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 2.51 per share.	31 Dec 2024	3,310	5,981 (0%)	0%	2.5	8,300	Common Stock
VistaGen Therapeutics Inc	Joshua S. Prince	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 2.96 per share.	28 Jun 2024	2,671	2,671 (0%)	0%	3.0	7,901	Common Stock
VistaGen Therapeutics Inc	Joshua S. Prince	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2024	150,000	150,000	-		-	Stock Option (Right to Buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades